Global Connected Drug Delivery Devices Market : Global Size, Trends, Competitive, And Historical & Forecast Analysis, 2022-2028: Theneed toboostpatientmedicationadherence,accelerationofremotedigital monitoring,andR&Dactivitiesaresomeofthemajorfactorsdrivingthe growthoftheGlobalConnectedDrugDeliveryDevicesMarket.
Global Connected Drug Delivery Devices Market is valued at USD 4.63 Billion in 2021 and expected to reach USD 7.99 Billion by 2028 with a CAGR of 50.21% over the forecast period.
Scope-
In residential settings, connected medication delivery devices are smart wireless electronic solutions that facilitate the monitoring of patients and counselling. They are equipped with adherence trackers, sensors, monitoring systems, dosage reminders, and teaching tools that provide real-time feedback and tailored patient care.
Key Players-
Some major key players for the global Connected Drug Delivery Devices market report cover prominent players like -
• Novo Nordisk A/S
• Teva Respiratory LLC
• Medtronic
• Phillips-Medisize LLC
• Tandem Diabetes Care Inc.
• Adherium Limited
• Propeller health
• Biocorp
• Ypsomed AG • Aptar Pharma
• others
Segmentation-
By Device Type:
• Connected Sensors
• Integrated Devices
By Technology:
• Bluetooth
• Near Field Communication
• Service
By Application:
• Respiratory
• Cardiovascular
• Anaphylaxis
• Hormone Replacement
• Diabetes
• Others
By End-Use:
• Hospital
• Clinics
• Homecare
• Others
By Regional & Country Level:
• NorthAmerica o U.S. o Canada • Europe o U.K. o France o Germany o Italy
• AsiaPacific o China o Japan o India o Southeast Asia
• LatinAmerica o Brazil o Mexico
• MiddleEastandAfrica o GCC
o Africa
o Rest of Middle East and Africa
The need to boost patient medication adherence, acceleration of remote digital monitoring, and R&D activities are some of the major factors driving the growth of the Global Connected Drug Delivery Devices Market Growth
One of the main factors driving the market is the rise in R&D activity. Due to the strong product offerings of numerous important participants, which is predicted to be commercially released throughout the projection period, it also adds to an exponentially growing rate.
North America is Expected to Capture a Major Share in the Global Connected Drug Delivery Devices Market
Due to the increased prevalence of chronic illnesses and the existence of a sizable target population, North America is predicted to be the region with the greatest market for linked medication delivery systems News-
Aptar Pharma Launches HeroTracker Sense
On February 8th, 2022; Aptar Pharma announced the launch of HeroTracker Sense,a breakthroughdigital respiratory healthcaresystem that transforms a typical metered dosage inhaler into a smart linked healthcare system. Aptar Pharma is a global leader in medication delivery devices, services, and active material science solutions.
Jabil Healthcare Announces the Launch of the Qfinity
On May 18th, 2022; A platform named QfinityTM autoinjector was introduced by Jabil Healthcare, a significant international provider of healthcare manufacturing solutions. When compared to other options on the market, this platform offers a reusable and integrated solution for subcutaneous (SC) medication self-administration at a reasonable cost.
Nemera inaugurated a new facility in Lyon
On September 19th, 2022; Nemera has opened a new facility in Lyon, France, which will serve as the company's current European headquarters and innovation hub.